Alerts will be sent to your verified email
Verify Email
VAISHALI
|
Vaishali Pharma
|
Denis Chem Lab
|
Bal Pharma
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
7.61 % | 9.47 % | 8.41 % |
|
5yr average Equity Multiplier
|
2.76 | 1.4 | 4.51 |
|
5yr Average Asset Turnover Ratio
|
0.89 | 1.46 | 1.01 |
|
5yr Avg Net Profit Margin
|
3.52 % | 4.57 % | 1.86 % |
|
Price to Book
|
2.0 | 1.5 | 1.68 |
|
P/E
|
327.79 | 15.06 | 18.13 |
|
5yr Avg Cash Conversion Cycle
|
133.52 Days | 5.37 Days | 27.6 Days |
|
Inventory Days
|
6.09 Days | 23.69 Days | 99.82 Days |
|
Days Receivable
|
217.95 Days | 65.58 Days | 115.65 Days |
|
Days Payable
|
174.07 Days | 89.52 Days | 154.91 Days |
|
5yr Average Interest Coverage Ratio
|
2.44 | 17.08 | 1.5 |
|
5yr Avg ROCE
|
16.76 % | 13.68 % | 19.2 % |
|
5yr Avg Operating Profit Margin
|
6.18 % | 10.7 % | 9.12 % |
|
5 yr average Debt to Equity
|
0.6 | 0.05 | 1.95 |
|
5yr CAGR Net Profit
|
88.82 % | 29.02 % | 8.78 % |
|
5yr Average Return on Assets
|
3.1 % | 6.85 % | 1.88 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
26.32 % | 38.98 % | 50.86 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-0.42 % | 0.0 | -1.14 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Vaishali Pharma
|
Denis Chem Lab
|
Bal Pharma
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|